To investigate the profile of these genetic aberrations, we analyzed the expression level of c-MET and TP53 mutation status based on The Cancer Genome Atlas-Liver Hepatocellular Carcinoma (TCGA LIHC) human HCC dataset [15]. The gene discussed is MET; the disease is hepatocellular carcinoma.